全文获取类型
收费全文 | 64652篇 |
免费 | 4919篇 |
国内免费 | 3274篇 |
专业分类
耳鼻咽喉 | 589篇 |
儿科学 | 2925篇 |
妇产科学 | 2133篇 |
基础医学 | 7675篇 |
口腔科学 | 2047篇 |
临床医学 | 4995篇 |
内科学 | 8992篇 |
皮肤病学 | 950篇 |
神经病学 | 3986篇 |
特种医学 | 1657篇 |
外国民族医学 | 34篇 |
外科学 | 6639篇 |
综合类 | 10071篇 |
现状与发展 | 15篇 |
预防医学 | 3601篇 |
眼科学 | 2505篇 |
药学 | 5713篇 |
18篇 | |
中国医学 | 1886篇 |
肿瘤学 | 6414篇 |
出版年
2024年 | 138篇 |
2023年 | 752篇 |
2022年 | 1636篇 |
2021年 | 2168篇 |
2020年 | 1828篇 |
2019年 | 1837篇 |
2018年 | 1752篇 |
2017年 | 1965篇 |
2016年 | 1996篇 |
2015年 | 2162篇 |
2014年 | 3787篇 |
2013年 | 4555篇 |
2012年 | 3723篇 |
2011年 | 4343篇 |
2010年 | 3653篇 |
2009年 | 3542篇 |
2008年 | 3676篇 |
2007年 | 3876篇 |
2006年 | 3453篇 |
2005年 | 3158篇 |
2004年 | 2633篇 |
2003年 | 2243篇 |
2002年 | 1867篇 |
2001年 | 1591篇 |
2000年 | 1381篇 |
1999年 | 1113篇 |
1998年 | 955篇 |
1997年 | 853篇 |
1996年 | 787篇 |
1995年 | 646篇 |
1994年 | 601篇 |
1993年 | 509篇 |
1992年 | 449篇 |
1991年 | 393篇 |
1990年 | 366篇 |
1989年 | 296篇 |
1988年 | 216篇 |
1987年 | 201篇 |
1986年 | 198篇 |
1985年 | 282篇 |
1984年 | 216篇 |
1983年 | 153篇 |
1982年 | 197篇 |
1981年 | 145篇 |
1980年 | 114篇 |
1979年 | 80篇 |
1978年 | 79篇 |
1977年 | 67篇 |
1976年 | 58篇 |
1973年 | 41篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
John T. Leith 《The Prostate》1994,24(3):119-124
Because there is extremely limited information on the intrinsic radiosensitivity of human prostatic cancer cells, we have investigated the in vitro radiation response of exponentially growing LNCaP cells. Due to the very poor colony-forming potential of the LNCaP cells, radiation survival was investigated using the dose-dependent (0-6 Gy) changes seen after X-irradiation in the shapes of regrowth curves. Survival was described using both the single-hit, multitarget (SHMT) equation and the linear-quadratic (LQ) equation. The values and 95% confidence limits of the extrapolation number (n), quasi-threshold dose (Dq), and mean lethal dose (Do) in SHMT terminology were respectively: 0.9 (0.7-1.0), 0.0 Gy, and 1.39 (0.11) Gy. The LQ alpha and beta parameters were respectively 6.80 (1.13) and -0.53 (2.89). The X-ray dose response of the LNCaP line is, therefore, purely exponential. The mean survival at the clinically relevant dose of 2 Gy (S2) was 51.2% for the LNCaP line. Comparison of the S2 value for the LNCaP line with previous investigations with other human prostatic cancer cell lines (DU145 and PC-3) indicates a mean S2 value of 47.6%, which suggests that human prostate cancer cells might lie toward the resistant side of the spectrum for various classes of human neoplasms. © 1994 Wiey-Liss, Inc. 相似文献
82.
J. D. Martins J. P. Monteiro M. C. Antunes-Madeira A. S. Jurado V. M. C. Madeira 《Toxicology in vitro》2003,17(5-6):595
Microorganisms are very powerful tools for the supply of information about the toxic effects of lipophilic compounds, since an impairment of cell growth usually occurs as a result of perturbations related, in most cases, with the partition of toxicants in membranes. The thermophilic eubacterium Bacillus stearothermophilus has been used as a model system to identify α- and β-endosulfan interactions with the membrane possibly related with the insecticide toxicity. Two approaches have been pursued: (a) bacterial growth is followed and the effects of endosulfan isomers determined; (b) biophysical studies with the fluorescent fluidity probe 1,6-diphenyl-1,3,5-hexatriene (DPH) were performed to assess the effects of α- and β-endosulfan on the organization of the membrane lipid bilayer. The effects on growth were quantitatively evaluated by determination of growth parameters, namely the lag phase, the specific growth rate and the cell density reached by cultures in the stationary phase. Growth inhibition by α and β-endosulfan dependent on the concentration is diminished or removed by the addition of 2.5 m
Ca2+ to bacterial cultures. Fluorescence DPH polarization consistently showed opposite effects of Ca2+ and α- and β-endosulfan on the physical state of bacterial polar lipid dispersions. 相似文献
83.
Michael B. Lee 《Journal of clinical periodontology》1997,24(6):355-365
Abstract For over 30 years now, research has been carried out to isolate and purify bone morphogenettc protein (BMP), a substance which has been shown to induce heterotopic bone formation in various animal species. Recent advances in the fields of developmental biology, molecular biology, genetics and wound healing, have shown that the BMPs are not only responsible for postfetal bone induction (including normal bone remodeling, healing and repair), but are also critical during embryogenesis, not only in regards to the skeletal system, but quite possibly in the morphogenesis and pattern formation of other tissues and organs as well, Therefore. BMPs have the potential as a therapeutic utility in orthopedic and dento-alveolar reconstruction. 相似文献
84.
K. S. Desyatnichenko A. A. Shreiner Yu. M. Ir'yanov S. N. Asonova S. A. Erofeev O. L. Grebneva S. N. Luneva E. L. Matveeva S. P. Isotova O. B. Ustyuzhanina 《Bulletin of experimental biology and medicine》1997,124(2):826-829
The effects of Stimbone-1, a complex of growth factors deposited by osteal tissue, on maturation of distraction regenerative
substrate are studied in dogs. At the end of distraction, the preparation is injected into the regenerative connective tissue
interlayer. Roentgenological, biochemical, and quantitative morphological data show that Stimbone-1 stimulates reparative
osteogenesis.
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 124, No. 8, pp. 233–236, August, 1997 相似文献
85.
In order to examine the effect of growth hormone on urinary pyridinoline excretion, 32 patients with complete or partial growth hormone deficiency had their urinary pyridinoline excretion measured while receiving growth hormone and for 14 days after it was discontinued. There was a significant positive correlation between increases in growth velocities during the first year of growth hormone administration compared to before it, and the ratio of the urinary pyridinoline excretion levels while receiving growth hormone to those after discontinuation. Therefore, urinary pyridinoline excretion rapidly decreased in patients with growth hormone deficiency when the administration of growth hormone was stopped. Exogenous growth hormone appears to stimulate bone resorption in these patients. 相似文献
86.
E. Alsat PhD J. Guibourdenche PhD D. Luton MD F. Frankenne PhD D. Evain-Brion MD PhD 《American journal of obstetrics and gynecology》1997,177(6):1526-1534
Placental growth hormone is the product of the GH-V gene specifically expressed in the syncytiotrophoblast layer of the human placenta. Placental growth hormone differs from pituitary growth hormone by 13 amino acids. It has high somatogenic and low lactogenic activities. Assays by specific monoclonal antibodies reveal that in the maternal circulation from 15 to 20 weeks up to term placental growth hormone gradually replaces pituitary growth hormone, which becomes undetectable. It is secreted by the placenta in a nonpulsatile manner. This continuous secretion appears to have important implications for physiologic adjustment to gestation and especially in the control of maternal insulin-like growth factor-I levels. Placental growth hormone secretion is inhibited by glucose in vitro and in vivo and is significantly decreased in the maternal circulation in pregnancies with intrauterine growth restriction. Placental growth hormone does not appear to have a direct effect on fetal growth because this hormone is not detectable in the fetal circulation. However, the physiologic role might also include a direct influence on placental development through an autocrine or paracrine mechanism, as suggested by the presence of specific growth hormone receptors in this tissue.(Am J Obstet Gynecol 1997;177:1526-34.) 相似文献
87.
Paola Sarchielli Andrea Alberti Beatrice Gallai Francesca Coppola Antonio Baldi Ardesio Floridi Virgilio Gallai 《The journal of headache and pain》2002,3(3):129-135
Little has been done to investigate the biochemical basis of chronic daily headache (CDH). Our group has recently demonstrated
an increase in the cerebrospinal fluid (CSF) levels of nerve growth factor (NGF) in CDH patients, supporting the involvement
of this growth factor in the abnormal processing of head pain in this pathological condition. Other members of the neurotrophin
family, especially brain-derived neurotrophic factor (BDNF), have been hypothesized as being involved in the development of
chronic head pain in patients affected by CDH, but so far no data are available on this subject. BDNF, NGF and glutamate levels
were determined in the CSF of 25 patients affected by CDH with a previous history of migraine. These levels were compared
with those of a group of 20 control subjects, for whom the CSF examination and other instrumental investigations excluded
diseases of the central and peripheral nervous systems. Significantly higher levels of BDNF, NGF and glutamate were found
in CDH patients compared with control subjects (p<0.0001, p<0.0002 and p<0.001, respectively). A significant positive correlation emerged between CSF values of BDNF and those of NGF (r=0.61, p<0.001) and glutamate (r=0.44, p<0.025) in CDH patients. No significant differences were detected in BDNF, NGF and glutamate levels between CDH patients with
analgesic overuse and those without. These results support the involvement of BDNF in CDH through the potentiation of glutamatergic
transmission involved in the processing of head pain. The significant correlation between BDNF and NGF levels suggests that
NGF-mediated up-regulation of BDNF in central sites involved in long-term sensitization plays a key role in persistent head
pain in CDH patients.
Correspondence to P. Sarchielli 相似文献
88.
RICHARD G. LEA JENNY UNDERWOOD KATHY C. FLANDERS HAL HIRTE DALJEET BANWATT SUZETTA FINOTTO ISAO OHNO SALIM DAYA CALVIN HARLEY MAGDY MICHEL JAMES F. MOWBRAY DAVID A. CLARK 《American journal of reproductive immunology (New York, N.Y. : 1989)》1995,34(1):52-64
PROBLEM : To determine if patients with unexplained recurrent miscarriage have a deficiency of decidual immunosuppressor cells that produce transforming growth factor β type 2, as has been found in mice with abortion due to rejection and/or trophoblast failure. METHODS : Decidual biopsy specimens were taken as near to the placental attachment site as possible under ultrasound guidance from first trimester legal termination (control) patients with recurrent miscarriage and non-viable pregnancy, and from patients with sporadic missed abortion. The tissue was tested for TGFβ-2+ suppressor cells by in situ hybridization, immunohistochemistry, and analysis of supernatants. RESULTS : TGFβ-2-related suppressor molecules similar but not identical to those identified in pregnant mice were released by decidual lymphoid cells. Fifty percent of 14 recurrent miscarriage patients showed a lack of suppressor cells and 59% were subnormal in comparison to 20 controls and 5 sporadic miscarriage patients, where 80–85% of the patients had detectable suppressor cells. CONCLUSIONS : Suppressor cell deficiency is compatible with a role for rejection and/or trophoblast failure in some patients with recurrent miscarriage. Presence of suppressor cells in most patients with missed abortion (4/5) is compatible with an alternative cause of fetal death, similar to findings reported in genetic fetal death mice. 相似文献
89.
90.